CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vivanza Biosciences Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vivanza Biosciences Ltd
403 Sarthik II, S G Road
Phone: +91 7926870952p:+91 7926870952 AHMEDABAD, 380054  India Ticker: 530057530057
Business Summary
Vivanza Biosciences Limited is an India-based specialty pharmaceutical company. The Company offers pharmaceutical products and pharma products. The Company is focused on commercializing generic pharmaceuticals, offering patients accessible medicines. The Company operates in only one that is trading of pharmaceutical product. Its products include gloves and surgical. Gloves products include latex examination gloves powdered, latex surgical powdered, latex free examination gloves-vinyl, latex free examination gloves-nitrile and Latex examination gloves-powdered. The Company’s products catalogues include Injectable Products, Vivanza Gloves and Therapeutic Index Injection. The Company offers gloves and surgical products to the industries include chemical, energy, industry, manufacturing and materials.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
3842 Orthopedic, prosthetic, and surgical appliances and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer Jainil R.Bhatt
Chief Compliance Officer, Company Secretary AvinashBhojwani 5/27/2022 5/27/2022
Managing Director, Executive Director Jayendra A.Mehta 4/25/2023 4/25/2023
3 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 40,000,000 (As of 9/30/2024)
Stock Exchange: BOM
Fax Number: +91 7965410862


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024